Le Deoxynivalenol (DON) est une mycotoxine majeure retrouvée dans l’alimentation animale et celle-ci est connue pour réduire la fertilité des truies en inhibant la sécrétion de progestérone par les cellules de granulosa. Chez le bétail, DON est métabolisée en de-epoxy DON (DOM-1) dans le rumen, et DOM-1 peut atteindre des concentrations élevées dans le sang et les liquides folliculaires. Une des voies majeures de signalisation activée par DON est le ribotoxic stress response (RSR), lequel induit une auto-phosphorylation de la protéine kinase R (PKR) et réduit l’activation des MAP kinases incluant la MAPK3/1. Il n’a pas encore été démontré que ces mycotoxines affectent la reproduction chez les bovins. Les objectifs de cette thèse sont (1) de déterminer comment et à quelles doses DON affecte la fonction des cellules de granulosa et d’élucider les mécanismes d’action entrant en jeu; et (2) déterminer comment et à quelles doses la mycotoxine majeure DON et son métabolite DOM-1, affectent la fonction des cellules de la thèque chez le bétail. Les résultats sont présentés dans trois articles distincts. Dans le premier article, nous explorons les effets de DON sur les cellules de granulosa bovines; les traitements avec DON résultant en une inhibition significative de la sécrétion d’oestradiol et de progestérone (P4), et en une augmentation de la proportion de cellules apoptotiques après 4 jours de traitement. Les expériences de Western-Blot démontrent une stimulation significative de la phosphorylation de ERK1/2 et de MAPK14 entre 15 et 30 minutes après le début du traitement des cellules par DON. Par la suite, nous avons déterminé les effets de DON sur les gènes cibles de ERK1/2. En effet, les niveaux d’ARNm de EGR1 et FOS sont transitoirement augmentés avec des niveaux maximum à 1h de traitement par DON, tandis que les niveaux d’ARNm de iv COX2 et GADD45B sont augmentés mais plus de 24h après le début du traitement par DON. Dans le second article, les effets de DON et DOM-1 sur les cellules de thèque ont été étudiés. Le traitement des cellules par DOM-1 résulte en une inhibition dosedépendante de la sécrétion de P4 et de testostérone, et en une augmentation de la proportion de cellules apoptotiques, tandis que DON inhibe la sécrétion de P4 sans altérer celle de la testostérone ou bien le pourcentage de cellules mortes. Les deux mycotoxines sont effectives de manière maximale à des concentrations de 1 ng/ml (en revanche, DON affecte les cellules de granulosa à 100 ng/ml). Les résultats de Western-Blot démontrent la phosphorylation rapide de MAPK3/1, PKR et de JUN kinase après un traitement par DON ou DOM-1. En présence d’un inhibiteur spécifique de PKR, DON et DOM-1 sont incapables d’induire la phosphorylation de MAPK3/1, et l’effet inhibiteur de DON sur la phosphorylation de MAPK14 est en partie abrogé. Néanmoins, l’inhibiteur de PKR augmente davantage la phosphorylation de MAPK14 induite par DOM-1. Ensemble, ces résultats suggèrent que DON active le RSR dans les cellules de thèque et les cellules de granulosa bovines, et que les cellules de la thèque sont plus sensibles que les cellules de granulosa aux effets de DON. Ces données démontrent pour la première fois l’habilité de DOM-1 à affecter les fonctions et la survie cellulaires. / Deoxynivalenol (DON) is a major mycotoxin found in animal feed and is known to reduce fertility in pigs by inhibiting progesterone secretion from granulosa cells. In cattle, it is metabolized to de-epoxy DON (DOM-1) in the rumen, and DOM-1 can reach high concentrations in blood and follicular fluid. One of the major pathways activated by DON is the ribotoxic stress response (RSR), which involves autophosphorylation of protein kinase R (PKR) and downstream activation of MAP kinases including MAPK3/1. It is not known if these mycotoxins affect bovine reproduction. The objectives of present thesis were (1) to determine how and at what doses DON affects ovarian granulosa cell function and to elucidate its mechanism of action; and (2) to determine how and at what doses major mycotoxin DON and its metabolite DOM-1 affect theca cell function in cattle. The results are separated into three articles. In the first article the effects of DON on granulosa cells were explored; treatment with DON resulted in a significant inhibition of estradiol and progesterone (P4) secretion, and an increase in the proportion of apoptotic cells after 4 days of treatment. Western blot demonstrated significant upregulation of ERK1/2 and MAPK14 phosphorylation within 15-30 minutes of adding DON. We then determined the effect of DON on ERK1/2 target genes; EGR1 and FOS mRNA levels were transiently stimulated with maximum levels at 1 h of adding DON, whereas COX2 and GADD45B mRNA levels were upregulated but not until 24 h after DON treatment. In the second article, the effects of DON and DOM-1 on theca cells were assessed. Treatment with DOM-1 resulted in a dose-dependent inhibition of P4 and testosterone secretion, and an increase in the proportion of apoptotic cells, while DON inhibited P4 but did not alter testosterone secretion or the percentage of dead cells. Both ii DON and its metabolite were maximally effective at concentrations of 1 ng/ml (in contrast, the effects of DON on occur at 100ng/ml). Western blot demonstrated rapid phosphorylation of MAPK3/1, PKR and of JUN kinase after addition of DOM-1 or DON. Interestingly, phosphorylation of MAPK14 was significantly increased by DOM-1 but decreased by DON. The addition of a PKR inhibitor abrogated the ability of DON and DOM-1 to increase phosphorylation of MAPK3/1, and partly abrogated the inhibitory effect of DON on MAPK14 phosphorylation, however, the PKR inhibitor further increased the phosphorylation of MAPK14 caused by DOM-1. Together, these results suggest that DON activates the RSR in bovine granulosa and theca cells, and that theca cells are more sensitive than granulosa cells to the effects of DON. The data also demonstrate for the first time in any cell type the ability of DOM-1 to affect cell function and health.

Les WNTs sont des glycoprotéines sécrétées impliquées dans plusieurs processus tels que la spécification cellulaire, la prolifération, la différenciation, et beaucoup d’autres. Pour transmettre leur signal, les WNTs se lient aux récepteurs Frizzled (FZD) et au co-récepteur « Low-density-lipoprotein receptor Related Protein » (LRP) 6 ou 5, activant ainsi l’une des trois principales voies de signalisation: la voie de signalisation WNT/β-caténine (voie canonique), la voie « Planar Cell Polarity » (PCP) et la voie WNT/Ca2+ (voies non-canoniques). Des antagonistes de cette voie, les « Secreted Frizzled Related Protein » (SFRPs), peuvent aussi se lier aux WNTs pour empêcher leur liaison aux récepteurs FZDs. Bien que des rôles importants aient été associés à plusieurs composants de la voie des WNTs lors de la régulation de l’ovaire adulte, le fonctionnement exact de cette signalisation reste nébuleux. L’objectif global de cette thèse visait donc à mieux comprendre la voie de signalisation des WNTs au niveau de l’ovaire adulte de souris, par la caractérisation de deux autres composants de cette voie, FZD1 et SFRP4. La création et l’analyse de souris Fzd1 et Sfrp4 KO ont démontré que FZD1 est nécessaire pour la régulation des gènes associés à l’expansion du cumulus, dans le complexe ovocyte-cumulus (COC). Nous avons aussi constaté que SFRP4 avait un rôle à jouer lors de la régulation des gènes associés à l’expansion du cumulus mais cette fois, au niveau des cellules de la granulosa. Finalement, les résultats in vivo et in vitro de cette étude ont suggéré que la voie PCP, contrairement à la voie canonique, pourrait être modulée dans les cellules de la granulosa des souris Sfrp4 KO, possiblement grâce au signal induit par WNT4 et WNT5a. Ces données ont permis de créer un modèle hypothétique représentant la régulation de la signalisation ovarienne par les WNTs. Ce modèle servira de base pour l’élaboration de futurs projets de recherche visant à comprendre davantage la signalisation ovarienne et les possibles effets de sa dérégulation lors de processus pathologiques. Ces connaissances pourront ensuite être appliquées chez l’humain afin de traiter plusieurs maladies ou dérèglements ovariens. / WNTs are secreted glycoproteins that act to regulate several processes such as cell fate determination, proliferation, differentiation and many more. To transmit their signal, WNTs bind the co-receptors Frizzled (FZD) and Low-density-lipoprotein receptor Related Protein (LRP) 6 or 5, which leads to the activation of one of three signaling pathways: WNT/β-catenin (canonical), Planar Cell Polarity (PCP) or WNT/Ca2+ pathways (both non-canonical). Secreted Frizzled Related Proteins (SFRPs) are antagonists of WNT signaling that act by directly binding WNTs and preventing their interaction with FZD receptors. Even if members of the WNT signaling pathway have been found to have important roles in adult ovarian regulation, the exact mechanism(s) involved remain poorly understood. The global objective of this thesis was to better understand WNT signaling in the adult rodent ovary, by characterizing two components of this pathway: FZD1 and SFRP4. Generation and analyses of Fzd1 and Sfrp4 KO mice first demonstrated that FZD1 is required for the induction of cumulus expansion-related genes, in the cumulus-oocyte complex (COC). Also, we demonstrated that SFRP4 is also required for the regulation of cumulus expansion-associated genes but this time, in mural granulosa cells. In vivo and in vitro data suggested that the PCP pathway, and not the canonical pathway, could be induced in granulosa cells of Sfrp4 KO mice, possibly by WNT4 and WNT5a. All the data presented herein permitted the creation of a hypothetical model that summarizes the roles of WNT signaling in ovarian regulation. This model will serve to develop new projects that will ultimately result in the better understanding of ovarian signaling and related pathological processes. This knowledge may then be useful for the treatment of many human ovarian disorders.

L’oestradiol joue un rôle important dans la reproduction en général, particulièrement dans la croissance folliculaire chez la vache. La production de l’œstradiol nécessite l’expression du gène CYP19A1 suite à la stimulation des cellules de granulosa par l’hormone folliculostimulante (FSH) ou le facteur de croissance insulinique de type 1 (IGF-1). Chez la vache, il existe six promoteurs (1.1 ; 1.2 ; 1.3 ; 1.4 ; 1.5 et 2) qui dirigent la transcription du gène CYP19A1 dans les cellules de la granulosa. Le principal promoteur qui dirige la transcription au niveau de l’ovaire (cellules de granulosa) est le promoteur 2 (P2). Cependant, l’effet de la FSH et de l’IGF-1 sur l’activation de ces promoteurs d’aromatase demeure mal connu. De plus, la demi-vie du transcrit CYP19A1 est très courte avec une région 3’UTR relativement longue. L’analyse de la séquence 3’UTR montre la présence des motifs ARE (séquence riche en AU), des études antérieur montrent que ces séquences impliquent dans la régulation de la stabilité ou la dégradation de l’ARNm, ce qui est fort probable que la courte demi-vie de l’ARNm CYP19A1 est sous le contrôle post-transcriptionel. L’objectif de la thèse visait à étudier la régulation de l’expression du gène CYP19A1 chez la vache. Il y a deux thèmes soit étude de la régulation transcriptionnelle ciblant le promoteur et soit étude de la régulation post-transcriptionnelle impliquant la région 3’non traduite (3’UTR). Le premier objectif vise à étudier la régulation transcriptionnelle du gène CYP19A1. Nous avons étudié l'activité du promoteur ovarien bovin dans deux modèles de cellules de la granulosa, les cellules lutéinisées et nonlutéinisées in vitro, suite à une stimulation des cellules par la FSH ou IGF-1. Nous avons également évalué la voie de signalisation impliquée dans la régulation des différents promoteurs en utilisant un RT-PCR et un gène rapporteur (les différents promoteurs d’aromatase ont été insérés dans le vecteur pGL3promoter en amont du gène exprimant la luciférase). Les résultats de RT-PCR démontrent que la FSH et l’IGF-1 augmentent les concentrations d’ARNm provenant des deux promoteurs 2 et 1.1 dans les cellules de la granulosa non lutéinisées. Des expériences subséquentes ont montré que la FSH stimule le promoteur 2 via la voie PKA tandis que l'IGF-1 stimule le promoteur 2 via la voie PKC. La FSH et l’IGF-1 stimulent l’expression du promoteur 1.1 via la voie PI3K. L’analyse de l’activité luciférase démontre que dans les cellules de granulosa lutéinisées, la FSH stimule le promoteur 1.1 de façon dose dépendante et ne semble y avoir aucun effet significatif sur le promoteur 2. Nous avons donc comparé l’activité du promoteur PII/P2 humain, du rat, de la chèvre et de la vache dans les cellules de granulosa bovine lutéinisées. Le résultat le plus significatif est que le promoteur 2 bovine (et caprine) dépend de plusieurs facteurs de transcription (NR5A2, FOXL2) comparé au promoteur PII humain et celui du promoteur proximal du rat qui dépendent principalement de l'AMPc. En effet, nos résultats ont démontré une expression raisonnablement robuste du P2 bovine lorsque les cellules sont traitées à la forskoline, NR5A2 et FOXL2. Le facteur FOXL2 semble déterminer l'activité du promoteur 2 chez le ruminant. Le deuxième objectif vise à étudier la régulation post-transcriptionnelle du gène CYP19A1. Pour ce faire, nous avons déterminé la séquence minimale de l'ARNm CYP19A1 requise pour la régulation de sa demi-vie. Différents séquences de la région 3’UTR ont été insérés dans le vecteur pGL3promoter en aval du gène exprimant la luciférase ou soit dans le vecteur pGEMTeasy. Le vecteur pGL3promoter a été transfecté dans les cellules de granulosa lutéinisées pour évaluer l'impact de la séquence 3'UTR sur l'expression du gène rapporteur de la luciférase, alors que le vecteur pGEMTeasy a été utilisé pour la transcription in vitro afin de générer de l’ARNm. Ce dernier sera utilisé en réaction croisée au UV avec des extraits protéiques pour démontrer l’association du complexe ARNm/protéine. L’analyse de l’activité luciférase a permis d’identifier une séquence de 200 pb située entre 926 et 1134 pb de la région 3'UTR de l’ARNm CYP19A1 qui a réduit significativement l’activité de la luciférase. Selon les analyses de la réaction croisée au UV, une ou plusieurs protéines de 66 et 80 kDA se lient spécifiquement à la séquence de 200 pb qui réduit l’activité de luciférase. Cette protéine s'exprime dans les cellules de granulosa, mais n’a pas été détectée dans d'autres tissus comme le foie et le cœur. Par ailleurs, l’utilisation du gène rapporteur sensible à la FSH a suscité l’intérêt d'une compagnie pharmaceutique qui vend de l’equine chorionic gonadotropin (eCG) pour lui permettre de distinguer facilement l’eCG ayant une forte activité FSH et donc, avoir un produit commercial plus efficace et de meilleure qualité. Dans cette étude, nous avons développé un système de bioessai à la FSH basé sur la transfection des cellules avec un récepteur à la FSH et un gène rapporteur colorimètrique qui permet d’estimer l’activité de la FSH dans le sérum de la jument et qui pourrait être applicable au niveau de la ferme/industrie. / Oestradiol plays an important role in reproduction in general, particularly during follicular growth. Production of estradiol requires the expression of CYP19A1 following stimulation of granulosa cells by follicle-stimulating hormone (FSH) and insulin like growth factor-1 (IGF-1). In cows, there are six promoters (1.1, 1.2, 1.3, 1.4 and 1.5 and 2) that direct transcription of CYP19A1, and promoter 2 (P2) is the major promoter used in granulosa cells. However the effect of FSH and IGF-1 on the activation of these promoters of aromatase remains unclear. Further, the CYP19A1 gene has a very short half-life and a long 3' non-translated region (3'UTR) that suggests post-transcriptional as well as transcriptional regulation. The aim of my PhD project is to study the regulation of the CYP19A1 gene in the cow. This summary is divided into two parts, the transcriptional regulation involving the promoter region and the post-transcriptional regulation involving the 3'UTR. The first part of my project was to study the transcriptional regulation of CYP19A1 gene; we measured the expression of the different promoters in luteinized or nonluteinized bovine granulosa cells following stimulation of cells with FSH or IGF-1. The results of RT-PCR showed that FSH and IGF-1 increases mRNA levels from both promoters 2 and 1.1 in non luteinized granulosa cells. Subsequent experiments showed that FSH stimulates the promoter 2 via the PKA pathway and IGF-1 stimulated promoter 2 via the PKC pathway. FSH and IGF-1 stimulate the expression of 1.1 via the PI3K pathway. In subsequent studies in luteinized cells with luciferase reporter genes driven by the specific CYP19A1 promoters, FSH stimulated promoter 1.1 in a dose dependent manner but that promoter 2 was weakly activated and not responsive to FSH. We then compared the activity of human, rat, goat and bovine promoters in luteinised bovine granulosa cells. The most significant result is that the bovine (and caprine) P2 depends on several transcription factors (NR5A2, FOXL2) whereas the human and rat promoters largely depend on cAMP. In fact, these data demonstrate a reasonably robust expression of the bovine P2 when treated with forskolin, NR5A2 and FOXL2. FOXL2 appears to be a determinant of promoter activity in ruminants. The second part of my project was to study the post-transcriptional regulation of the CYP19A1 gene. The objective was to identify the elements required for the regulation of the half-life of CYP19A1 mRNA. To do so, we generated and inserted different fragments of the 3'UTR region of CYP19A1 mRNA in the pGL3promoter vector downstream of the luciferase gene, which was then transfected into luteinized granulosa cells to assess the impact of the 3'UTR sequence on the expression of luciferase reporter gene. We identified a sequence of 200 bp between 926 and 1134 bp of the 3'UTR region of CYP19A1 mRNA that significantly reduced luciferase activity. The same fragments were inserted into the pGEMTeasy vector for in vitro transcription and the generation of mRNA for UV crosslinking with protein extracts to demonstrate the presence of mRNA/protein complexes. We detected protein complexes of 66 and 80KDA that specifically bound to the 200 pb probe. This protein is expressed in granulosa cells but not in other tissues such as the liver and heart. The use of reporter gene attracted the interest of a company producing equine chorionic gonadotropin (eCG), and an interest was expessed in developing this system to measure the FSH-like bioactivity in eCG, and therefore have a more effective commercial product. In this study, we developed a FSH bioassay system based on the transfection of cells with an the FSH receptor and a colorimetric reporter gene to estimate the activity of FSH in the serum of the mare ; these results may be applicable at the farm / industry.

OBJETIVO: avaliação da expressão gênicado receptor do fator de crescimento semelhante à insulina de (Insulin-Like Growth Factor- IGF) 1 em células da granulosa luteinizadas do cumulusde mulheres não obesas, com sensibilidade à insulina normal, com síndrome dos ovários policísticos (SOP) tratadas e não tratadas com metformina. MODELO DO ESTUDO: prospectivo, longitudinal, randomizado. PACIENTES E MÉTODOS: avaliamos 12 mulheres com ciclosovulatórios, 9 mulheres com SOP e 8 mulheres com SOP e tratadas com metformina, ao menos 8 semanas na dose de 1.700 mg/dia. Todos os grupos foram similares com relação ao peso, ao índice de massa corporal (IMC), à circunferência da cintura e com sensibilidade à insulina normal. Todas as mulheres foram submetidas à estimulação ovariana controlada com uso de agonista de GnRH em protocolo longo e gonadotrofinas para ciclos de FIV/ICSI. As células da granulosa do cumulusforam obtidas por microdissecção dos cinco maiores folículos pré-ovulatórios. A expressão gênica do receptor de IGF-1 foi determinada com técnica da Reação da Polimerase em Cadeia a partir da Transcrição Reversa (Reverse transcriptase - Polymerase Chain ReactionRT-PCR) emiquantitativa. Foram avaliadas as concentrações séricas e foliculares de estradiol, progesterona, testosterona, hormônio folículo estimulante (Follicle-Stimulating Hormone- FSH), hormônio luteinizante (Luteinizing Hormone - LH), Sex Hormone-Binding Globulin(SHBG), glicose, insulina e IGF-1. Para análise estatística, foram utilizados os testes: ANOVA, Newman-Keuls, coeficiente de Pearsone regressão linear múltipla, sendo considerado nível de significância de 5%. RESULTADOS: não foram observadas diferenças com relação à expressão gênica do receptor de IGF-1 nos três grupos analisados (P>0,05). O número de oócitos (20,4 vs. 13,1 vs.11,5, P= 0,009), os níveis séricos de estradiol (1.896,00 pcg/mL vs. 985,20 pcg/mL vs.908,10 pcg/mL,P = 0,03) e testosterona (1,43 ng/mL vs.0,89 ng/mL vs. 0,82 ng/mL pcg/mL,P = 0,02) foram maiores no grupo de mulheres com SOP não tratadas com metformina em comparação com as mulheres com ciclos ovulatórios e tratadas com metformina, respectivamente. As mulheres com ciclos ovulatórios (50.710±42.520 ng/mL) apresentaram maiores concentrações foliculares de progesterona quando comparados com as mulheres com SOP tratadas (13.660±5.212 ng/mL) e não tratadas com metformina (17.680±6.644 ng/mL) (P=0,01). Na avaliação da regressão múltipla, a testosterona sérica não sofreu influência da expressão gênica do receptor de IGF-1 ou do IMC. CONCLUSÕES: as altas concentrações séricas de estradiol e testosterona, maior número de oócitos no grupo de mulheres com SOP não tratadas com metformina nos levam a concluir que mulheres com SOP provavelmente têm uma maior sensibilidade à estimulação da esteroidogênese ovariana quando comparadas com mulheres sem essa doença, embora não tenhasido encontrada diferença na expressão do receptor de IGF-1 nos trêsgrupos analisados. A similaridade dos resultados deste estudo entre mulheres com SOP tratadas com metformina e com ciclos ovulatórios nos levam a \"hipotetizar\" que um dos possíveis mecanismos de ação da metformina no sistema IGF-1 nas células da granulosa do cumulus poderia ser por mecanismos pós-receptores. / OBJECTIVE: evaluation of the gene expression of the IGF-I receptor in luteinized cumulus granulosa cells from non-obese women with normal insulin sensitivity and with polycystic ovarian syndrome (PCOS)treated or nor with metformin. STUDY MODEL: prospective,longitudinal, randomized. PATIENTS AND METHODS: we evaluated 12 women withovulatory cycles and 9 women with PCOS who had been treated for at least 8 weeks with a metformin dose of 1700 mg/day. All groups were similar interms of weight, body mass index (BMI), and waist circumference and all had normal insulin sensitivity. All women were submitted to controlled ovarian stimulation with a GnRH agonist in a long protocol and with gonadotropins for IVF/ICSI cycles. Cumulus granulosa cells were obtained by microdissection of the five largest pre-ovulatory follicles. Gene expression of the IGF-1 receptor was determined by semiquantitative RT-PCR. Serum and follicular concentrations of estradiol, progesterone, testosterone, FSH, LH, insulin, SHBG, and IGF-1 were determined. Data were analyzed statistically by ANOVA and by the Newman-Keuls test and the Pearson coefficient and linear multiple regression were calculated, with the level of significance set at 5%. RESULTS: no difference in geneexpression of the IGF-I receptor were observed between the three groups studied (P>0.05). The number of oocytes (20.4 vs. 13.1 vs. 11.5, P= 0.009) and the serum levels of estradiol (1,896.00 pcg/mL vs. 985.20 pcg/mL vs.908.10 pcg/mL,P = 0.03) and testosterone (1.43 ng/mL vs.0.89 ng/mL vs. 0.82 ng/mL pcg/mL,P = 0.02) were higher in the group of women with PCOS not treated with metformin than in women with ovulatory cycles and in women treated with metformin, respectively. The women with ovulatory cycles (50.710±42.520 ng/mL) presented higher follicular concentrations of progesterone compared with women with PCOS treated (13.660±5.212 ng/mL) or not with metformin (17.680±6.644 ng/mL) (P=0.01). Multiple regression revealed that serum testosterone was not affected by the gene expression of the IGF-1 receptor or by BMI. CONCLUSIONS: the high serum concentrations of estradiol and testosterone and the larger number of oocytes in the group ofwomen with PCOS not treated with metformin lead us to conclude that women with PCOS probably have greater sensitivity to stimulation ofovarian steroidogenesis than women without the disease, although no difference was detected in the expression of the IGF-I receptor between the three groups studied. The similarity ofthe present results for the women with PCOS treated with metformin and for the women with ovulatory cycles leads us to hypothesize that one of the possible mechanisms of action of metformin on the IGF-1 system in cumulus granulosa cells may be of the post-receptor type.

L’hormone anti-Müllerienne (AMH) est un membre de la famille TGF-β impliquée dans la différenciation du tractus reproductif mâle. Elle est aussi exprimée par les cellules de la granulosa de l’ovaire adulte. Cependant, son rôle physiologique chez la femelle n’a pas encore été entièrement établi. Mon projet de thèse a pour objectif d’élucider le(s) rôle(s) de l’AMH dans le tractus reproductif femelle. L’AMH transduit ses effets par l’intermédiaire de deux récepteurs transmembranaires sérine/thréonine kinase : un récepteur de type II qui lui est spécifique (AMHR-II) et un récepteur de type I (ActR-IA, BMPR-IA, BMPR-IB) qu’elle partage avec les BMPs. Après fixation de l’hormone sur le récepteur de type II, celui-ci recrute et phosphoryle le récepteur de type I. Ce dernier phosphoryle à son tour les Smads spécifiques (Smad1, 5 et 8) qui s’associent à la Smad commune, Smad4. L’ensemble transloque dans le noyau et en association avec des facteurs de transcription régule les gènes cibles de l’hormone. L'utilisation de souris KO conditionnelles pour les récepteurs Acvr1 et Bmpr1a et d'une technique de siRNA dirigés contre chacun des trois récepteurs de type I a permis de mettre en évidence que le récepteur BMPR-IA est un acteur essentiel de la voie de signalisation de l'AMH dans les cellules de la granulosa. Pour déterminer la ou les Smad(s) impliquées, une technique de gènes rapporteurs, Smad-Gal4/UAS-luciférase, a été utilisée. Nous avons pu montrer que les Smad1 et 5 sont importantes pour la transduction du signal de l'AMH dans les cellules de la granulosa. Récemment des corécepteurs aux BMPs, les Repulsive Guidance Molecule (RGMs), ont été mis en évidence. L’AMH partageant sa voie de signalisation avec les BMPs, nous avons cherché à déterminer si ces corécepteurs pouvaient également intervenir dans la voie de signalisation de l’AMH. Il existe 3 types de RGMs: RGMa, RGMb et RGMc. Nous avons montré en q-PCR que seul RGMb est exprimé dans les cellules de la granulosa alors que les 3 RGMs sont exprimés dans l’ovaire. L'utilisation de siRNA dirigés contre RGMb a permis de montrer que ce récepteur n'est pas nécessaire à la transduction du signal de l'AMH. Actuellement, seuls deux gènes cibles de l’AMH sont connus dans les cellules de la granulosa : l’aromatase et le récepteur LH. Nous avons réalisé des analyses de puces à ADN (ou micro-array) pour décrire de nouveaux gènes cibles de l'AMH. L'analyse des puces a permis de décrire de nouveaux gènes régulés par cette hormone tels qu’Ovgp1 ou Kcnj2. La dernière partie de mon projet visait à déterminer un rôle potentiel de l'AMH dans l'utérus. En effet, le récepteur de cette hormone est exprimé dans le myomètre utérin de souris permettant de supposer qu’elle peut agir sur cet organe. Nous avons pu mettre en évidence une expression faible du gène de l’Amh dans l’utérus. En revanche, l’expression et la localisation de la protéine restent encore à définir. Une expérience de PCR-array a permis de montrer que de nombreux gènes sont différentiellement exprimés entre l’utérus Wt et l’utérus KO Amh. Ceci indique que l’AMH jouerait un rôle sur la régulation de la fonction utérine qu’elle soit exprimée ou non dans cet organe. / Anti-Müllerian hormone (AMH) is a member of the TGF-ß superfamily. AMH is well known for its role in Müllerian duct regression in male fetuses. Postnatally, AMH is secreted by granulosa cells (GCs) of small growing follicles (preantral and small antral). However, despite the increasing interest of ovarian AMH in clinics, little is known on its mechanism of action and its role in female reproductive tract. My PhD project focuses on the identification of AMH function in the female reproductive tract.AMH signals through a type II transmembrane serine/threonine kinase receptor (AMHR-II) which forms a complex with a type I serine/threonine kinase receptor (ActR-IA, BMPR-IA, BMPR-IB). The type II receptor phosphorylates serine and threonine residues of type I receptor. Once activated, the type I receptor phosphorylates the receptor-regulated Smads (R-Smad1/5/8) which interact with a common partner Smad4. The Smad complex accumulates into the nucleus and regulates target gene expression. This canonical signalling pathway is regulated at different levels, in particular by co-receptors which amplify or antagonize TGF-ß family members action. The type I receptors and R-Smads involved in AMH effects on post-natal GCs remain unknown. In addition, to date, no co-receptor has been found for AMH. To define the involvement of the different type I receptors, we used siRNA technology to inactivate Acvr1, Bmpr1a and Bmpr1b in GC. In parallele, we analysed GC extracted from conditional mutant mice for Acvr1 and Bmpr1a. We found that BMPR-IA is the most important type I receptor for AMH to transduce its signal in GC. A Smad-Gal4/UAS-luciferase reporter gene technology allowed us to show that Smad1 and 5 are involved in AMH signaling pathway. Recently, new BMPs coreceptors were found, RGMs for Repulsive Guidance Molecules. There are three RGMs : RGMa, b and c. Because AMH shares with BMPs its type I receptors and R-Smad proteins, we hypothesized that they also share the same co-receptors, the RGM. We showed that RGMb was the only one expressed in GC and after siRNA transfection we demonstrated that this coreceptor is not essential for AMH to transduce its signal.To date, only few AMH target genes have been identified. Aromatase (Cyp19a1) and LH receptor (Lhcgr) are down-regulated by AMH in rat and porcine GCs. We used micro-array technology (Affymetrix) by comparing Wt and knockout immature ovaries to find new AMH target genes. This experiment evidenced that Ovgp1 and Kcnj2 are two new potential AMH target genes in the ovary.The last part of my project was to define a potential role of AMH in murine uterus. Only one study showed that AMHR-II is expressed in the mouse myometrium. We showed that Amh gene is slightly expressed in uterus but the results are not confirmed at the protein level. Using PCR-array, we found a lot of differentially expressed genes between Wt and Amh KO uterus. Therefore, AMH could regulate uterine function through the modulation of different genes located in the myometrium.

Les WNTs sont des glycoprotéines sécrétées impliquées dans plusieurs processus tels que la spécification cellulaire, la prolifération, la différenciation, et beaucoup d’autres. Pour transmettre leur signal, les WNTs se lient aux récepteurs Frizzled (FZD) et au co-récepteur « Low-density-lipoprotein receptor Related Protein » (LRP) 6 ou 5, activant ainsi l’une des trois principales voies de signalisation: la voie de signalisation WNT/β-caténine (voie canonique), la voie « Planar Cell Polarity » (PCP) et la voie WNT/Ca2+ (voies non-canoniques). Des antagonistes de cette voie, les « Secreted Frizzled Related Protein » (SFRPs), peuvent aussi se lier aux WNTs pour empêcher leur liaison aux récepteurs FZDs. Bien que des rôles importants aient été associés à plusieurs composants de la voie des WNTs lors de la régulation de l’ovaire adulte, le fonctionnement exact de cette signalisation reste nébuleux. L’objectif global de cette thèse visait donc à mieux comprendre la voie de signalisation des WNTs au niveau de l’ovaire adulte de souris, par la caractérisation de deux autres composants de cette voie, FZD1 et SFRP4. La création et l’analyse de souris Fzd1 et Sfrp4 KO ont démontré que FZD1 est nécessaire pour la régulation des gènes associés à l’expansion du cumulus, dans le complexe ovocyte-cumulus (COC). Nous avons aussi constaté que SFRP4 avait un rôle à jouer lors de la régulation des gènes associés à l’expansion du cumulus mais cette fois, au niveau des cellules de la granulosa. Finalement, les résultats in vivo et in vitro de cette étude ont suggéré que la voie PCP, contrairement à la voie canonique, pourrait être modulée dans les cellules de la granulosa des souris Sfrp4 KO, possiblement grâce au signal induit par WNT4 et WNT5a. Ces données ont permis de créer un modèle hypothétique représentant la régulation de la signalisation ovarienne par les WNTs. Ce modèle servira de base pour l’élaboration de futurs projets de recherche visant à comprendre davantage la signalisation ovarienne et les possibles effets de sa dérégulation lors de processus pathologiques. Ces connaissances pourront ensuite être appliquées chez l’humain afin de traiter plusieurs maladies ou dérèglements ovariens. / WNTs are secreted glycoproteins that act to regulate several processes such as cell fate determination, proliferation, differentiation and many more. To transmit their signal, WNTs bind the co-receptors Frizzled (FZD) and Low-density-lipoprotein receptor Related Protein (LRP) 6 or 5, which leads to the activation of one of three signaling pathways: WNT/β-catenin (canonical), Planar Cell Polarity (PCP) or WNT/Ca2+ pathways (both non-canonical). Secreted Frizzled Related Proteins (SFRPs) are antagonists of WNT signaling that act by directly binding WNTs and preventing their interaction with FZD receptors. Even if members of the WNT signaling pathway have been found to have important roles in adult ovarian regulation, the exact mechanism(s) involved remain poorly understood. The global objective of this thesis was to better understand WNT signaling in the adult rodent ovary, by characterizing two components of this pathway: FZD1 and SFRP4. Generation and analyses of Fzd1 and Sfrp4 KO mice first demonstrated that FZD1 is required for the induction of cumulus expansion-related genes, in the cumulus-oocyte complex (COC). Also, we demonstrated that SFRP4 is also required for the regulation of cumulus expansion-associated genes but this time, in mural granulosa cells. In vivo and in vitro data suggested that the PCP pathway, and not the canonical pathway, could be induced in granulosa cells of Sfrp4 KO mice, possibly by WNT4 and WNT5a. All the data presented herein permitted the creation of a hypothetical model that summarizes the roles of WNT signaling in ovarian regulation. This model will serve to develop new projects that will ultimately result in the better understanding of ovarian signaling and related pathological processes. This knowledge may then be useful for the treatment of many human ovarian disorders.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / In the first study, we characterized an in vitro culture system able to delaying meiosis resumption of bovine oocytes. Firstly, we demonstrated that the use of an EGFR inhibitor (AG1478; 5μM) in a culture system with follicular hemisections (FHS) was effective to maintain 89.3% of the oocytes in germinal vesicle stage (GV) during 15 h. This blocking effect was dependent on the FHS, since in its absence only 40% of the oocytes remain in GV stage. The meiosis blockage was totally reversible, since the oocytes reached matured stages after an additional 18 and 20 h maturation period and were able to support the embryonic development after in vitro fertilization. Regarding the molecular profile of the cells involved in the blocking system, we did not observe treatment effect on mRNA expression of the genes evaluated in oocyte. However, in cumulus cells, whereas the expression of EGR-1, TNFAIP6 and HAS2 was inhibited by AG1478 treatment, the expression of CX43 and IMPDH1 was decreased by FHS influence. Moreover, in the granulosa cells we observed a downregulation in the expression levels of PGR and ADAMTS1 by AG1478 treatment. The Western blot data revealed that the treatment with AG1478 plus FHS induces a downregulation in p-ERK1/2 protein abundance. In the next experiment, we verified that the AngII or PGE2 and PGF2α did not reverse the inhibitory effect of AG1478 plus FHS on meiosis resumption. In conclusion, findings from this study revealed an effective and reversible system to prevent meiosis resumption of bovine oocytes. In the second study, we investigate the role of mTOR system and its relation with LH regulated genes during preovulatory period in cattle. Using an in vivo model, we demonstrated mTOR kinase activity in granulosa cells 3 and 6 h after induction of ovulation with GnRH. In the similar moments (3 h after GnRH), we observed an increase in p-ERK1/2, STAR and EGR1 protein abundance. The inhibition of mTOR kinase activity by intrafollicular injection of rapamycin did not alter the ovulation rate. However, the treatment of granulosa cells in vitro with rapamycin interrupted the LH-induced increase in EREG mRNA levels. Moreover, the effect of rapamycin in culture was proved by inhibiting the p-P70S6K protein levels. In the same Western blot analysis, we verified that rapamycin may be inducing AKT activity and did not alter Phospho-ERK1/2 status and EGR1 protein abundance. These results provided the first evidence in cattle that mTOR system is upregulated by LH at time points similar to p-ERK1/2, STAR and EGR1. In addition, the mTOR inhibition data contribute to suggest an AKT dependent pathway during ovulation process, in which occurs ERK1/2 activation in a pathway independent of EREG, AREG and PTGS2 mRNA levels. / O primeiro estudo caracterizou um modelo in vitro de bloqueio do reinício da meiose de oócitos bovinos. Em um primeiro momento, demonstramos que o uso de um inibidor dos EGFR (AG1478; 5μM) em um sistema de cultivo com metades foliculares (FHS) foi eficiente para manter 89,3% dos oócitos em vesícula germinativa durante 15 h. Esse efeito de bloqueio foi dependente das FHS uma vez que na sua ausência apenas 40% dos oócitos permanecem em vesícula germinativa. O sistema de bloqueio foi totalmente reversível, tendo em vista que os oócitos completaram a maturação após um período adicional de 18 e 20 h, e suportaram o desenvolvimento embrionário subsequente após fertilização in vitro. Quanto ao perfil molecular das células envolvidas no bloqueio, no oócito não foi verificado efeito do tratamento na expressão dos genes avaliados. Entretanto, nas células do cumulus, enquanto a expressão de EGR1, TNFAIP6 e HAS2 foi diminuída pelo tratamento com AG1478, a expressão de CX43 e IMPDH1 foi diminuída pela influência das FHS. Além disso, nas células da granulosa observamos uma diminuição nos níveis de expressão de PGR e ADAMTS1 pelo tratamento com AG1478. Os dados de Western blot nos mostraram que a abundância de p-ERK1/2 diminui em decorrência do tratamento com AG1478 associado as FHS. Posteriormente, verificamos que o efeito inibitório do AG1478 juntamente com as FHS não foi revertido pelo tratamento com AngII ou PGs. Em conclusão, este estudo propõem um modelo efetivo e reversível para o bloqueio do reinício da meiose de oócitos bovinos. Em um segundo estudo, investigamos o papel do sistema mTOR e sua relação com genes regulados pelo LH durante o período pré-ovulatório em bovinos. Utilizando um modelo in vivo, demonstramos que ocorre um aumento na atividade do mTOR em células da granulosa 3 e 6 h após indução da ovulação com GnRH. Em momentos similares (3 h após GnRH) ocorreu maior abundância proteica para p-ERK1/2, STAR e EGR1. Ao injetar rapamicina no ambiente intrafolicular in vivo, não foram observadas alterações nas taxas de ovulação. Entretanto, o uso da rapamicina em cultivo in vitro de células da granulosa inibiu a expressão de RNAm para EREG induzida pelo LH. Além disso, os dados de cultivo comprovaram o efeito da rapamicina em bloquear a atividade do mTOR, caracterizada pela abundância proteica de p-P70S6K, induzir um provável aumento na abundância de p-AKT e não alterar os níveis de p-ERK1/2 e EGR1. Esses resultados fornecem a primeira evidência em bovinos que o sistema mTOR é regulado positivamente pelo LH em momentos similares a p-ERK1/2, STAR e EGR1. Além disso, os dados de inibição do mTOR contribuem para sugerir uma outra rota para a ovulação controlada pela p-AKT, na qual ocorre ativação de ERK1/2 em uma via independente dos níveis de expressão de EREG, AREG e PTGS2.

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / The objectives of the present study was to determine the concentration of angiotensin II (AngII) in follicular fluid, to characterize the expression of renin-angiotensin system (RAS) genes in follicular cells and to verify the role of AngII in the follicular wave, using an in vivo model with intrafollicular injection and in vitro model with granulosa cells culture. AngII concentration in follicular fluid increased on dominant follicle during and after deviation. Saralasin inhibited follicular growth in all treated cows (4/4), suggesting that AngII is essential for follicular growth in 7-8mm follicles. However, intrafollicular injection of AngII affected neither follicular growth nor the pattern of follicular dynamics, which were similar to control cows. These results imply that bovine ovarian follicles contain sufficient AngII for follicle development. In another experiment, saralasin inhibitory effect was overcome by systemic FSH supplementation, suggesting that AngII is essential to follicular growth during FSH-low dependence stages. The injection of AngII or angiotensin receptor type 2 (AGTR2) agonist in second largest follicle prevented the expected atresia of subordinate follicle and the treated follicle grew at the same rate as the dominant during 24h. To understand why a single intrafollicular injection of AngII antagonist induces follicular atresia, dominant follicle was injected with saralasin or saline and the cows were ovariectomized 24h later. The inhibition of AngII action decreased estradiol concentration in follicular fluid and abundance of mRNA encoding aromatase (CYP19), 3!-hydroxysteroid dehydrogenase (3!HSD), LH receptor, SerpinE2 and cyclinD2 in granulosa cells. On granulosa cell culture, AngII increased CYP19 expression just in the presence of FSH. Taken together, these results show that AngII is essential for follicular growth, and plays important role in regulating genes involved in granulosa cell proliferation (cyclinD2) and differentiation (LHr, aromatase, 3!HSD), which are necessary for development of the dominant follicle. In conclusion, these data suggest that AngII signaling is involved in follicle growth and dominance in cattle. / Os objetivos do presente trabalho foram determinar a concentração de angiotensina II (AngII) no fluido folicular, caracterizar a expressão dos genes do sistema renina-angiotensina (RAS) nas células foliculares e verificar o papel da AngII na onda folicular, utilizando um modelo in vivo de injeção intrafolicular e in vitro de cultivo de células da granulosa. A concentração de AngII no fluido folicular aumentou no folículo de maior diâmetro, durante e após a divergência folicular. A administração intrafolicular de saralasina, um bloqueador competitivo dos receptores de AngII, inibiu o crescimento folicular em todas as vacas injetadas (4/4), demonstrando que a AngII é essencial para o crescimento de folículos de 7-8mm de diâmetro. Contudo, a injeção de AngII não afetou o crescimento folicular, sugerindo que os folículos contém AngII suficiente para o seu desenvolvimento. Em um outro experimento, a administração sistêmica de FSH reverteu o efeito inibitório da saralasina, sugerindo que a AngII é indispensável para o desenvolvimento folicular após o período de dependência ao FSH. A injeção, no segundo maior folículo, de AngII ou CGP42122 (agonista AGTR2) preveniu a regressão esperada do folículo subordinado, demonstrando que a AngII desempenha um papel fundamental na seleção do folículo dominante. Para determinar o mecanismo de atresia induzido por saralasina, o folículo dominante de cada vaca foi injetado com saralasina ou solução salina e os animais foram ovariectomizados após 24 horas. A inibição de AngII diminuiu a concentração de estradiol no fluido folicular e a abundância de mRNA que codifica para os genes aromatase (CYP19), 3! HSD, LHr, Serpin E2 e ciclina D2 nas células da granulosa. Além disso, em cultivo primário de células da granulosa, a AngII, somente na presença do FSH, induziu um aumento na expressão de aromatase. Em resumo, os resultados demonstram que a sinalização da AngII é essencial para o crescimento folicular, regulando genes envolvidos com a proliferação (ciclina D2) e diferenciação (LHr, aromatase, 3!HSD) das células da granulosa os quais são necessários para o desenvolvimento do folículo dominante. Em conclusão, os resultados sugerem que a AngII está envolvida no desenvolvimento e dominância folicular em bovinos.

This thesis aims to contribute to the knowledge of the regulation and function of the natriuretic peptide (NP) system during follicular dominance, ovulation, oocyte meiosis resumption and cumulus cells expansion in cattle. In the first study, the NP system was characterized in bovine COC. Moreover, NPPA and NPPC increased cGMP levels in cumulus cells and oocyte after 3 hours of culture, preventing the increase of cAMP in oocyte in the presence of forskolin. In the second study, using in vivo experimental models, none of the three NPs were detected in the granulosa cells during follicular deviation in cattle. However, NPR-3 is highly expressed at the expected time of follicular deviation, and all three NP receptors are expressed in granulosa cells of the dominant follicle. FSH injection maintained the expression of the three NP receptors after follicular deviation in the largest and second largest follicles. However, only NPR-1 mRNA decreased after inhibition of estradiol receptors by intrafollicular injection of fulvestrant. In the granulosa cells of pre ovulatory follicles, only NPPB mRNA was not detected. Nevertheless, after the administration of a GnRH analog, NPPC mRNA expression increased within 3 and 6 hours and NPR-3 mRNA gradually decreased after 3 hours. NPPA and NPR-2 mRNA was not regulated by GnRH, but NPR-1 mRNA increased at 24 hours after GnRH. In the third study, abundance of mRNA for NPR-1, NPR-2 and NPR-3 was not altered by LH and/or AG1478 (EGFr inhibitor) after 6 hours of culture in vitro. Also, LH stimulated NPPC mRNA expression and AG1478 prevented this increase in granulosa cultured in vitro. To confirm the in vitro results, was used an in vivo model and observed that the NPPC mRNA expression increased and NPR-3 mRNA decreased in granulosa cells after 6 hours of GnRH challenge. However, intrafollicular injection of AG1478 prevented the effect of GnRH on NPPC and NPR-3 mRNA expression. In addition, it we obseved that ANP in association with LH stimulated COX2 expression in comparison with LH alone or absence of this gonadotropin. It was observed that the EGFr blockade in vivo did not prevent ovulation in cattle. In the fourth study, it was observed that NPR-3 mRNA expression decreases in bovine cumulus cells after treatment of COCs with FSH or FSH+LH via EGFr. Forskolin, an adenylate cyclase stimulator, also decreased NPR-3 mRNA expression in cumulus cells. Expression of NPR-1 mRNA was very low in bovine cumulus cells and NPR-2 mRNA was not regulated in the proposed treatments. In addition, it was observed that the activation of NPR-3 by a specific agonist (cANP4-23) did not interfere in bovine oocyte nuclear maturation, but it inhibited the complete expansion of cumulus cells FSH+LH-stimulated. Additionally, the association of cANP4-23 with CNP further decreased cumulus cell expansion. / Esta tese tem como objetivo contribuir para o conhecimento da regulação e função do sistema dos peptídeos natriuréticos (NP) durante a dominância folicular, ovulação, retomada da meiose oocitária e expansão das células do cumulus em bovinos. No primeiro estudo, caracterizou-se o sistema NP no CCO de bovino e foi demonstrado que o NPPA e o NPPC aumentam os níveis de cGMP no cumulus e no oócito após 3 horas de cultivo, impedindo o aumento de cAMP no oócito na presença de forskolin. No segundo estudo, utilizando modelos experimentais in vivo, os três NPs não foram detectados nas células da granulosa durante a divergência folicular em bovinos. Contudo, demonstrou-se que o NPR-3 apresenta maior expressão no momento esperado da divergência folicular, sendo que após este momento os três receptores NPs apresentavam alta expressão nas células da granulosa do folículo dominante. A administração de FSH manteve a expressão dos três receptores NPs após a divergência folicular no maior e segundo maior folículo. Porém, somente a expressão do NPR-1 diminui após a inibição dos receptores de estradiol pela injeção intrafolicular de fulvestrant. Nas células da granulosa de folículos pré ovulatórios, somente o NPPB não foi detectado. De modo que, após a administração de um análogo de GnRH, a expressão de NPPC aumentou em 3 e 6 horas e a de NPR-3 gradualmente diminuiu após 3 horas. NPPA e NPR-2 não foram regulados pelo GnRH, e o NPR-1 teve a expressão aumentada somente 24 horas após o GnRH. No terceiro estudo, a abundância de mRNA para NPR-1, NPR-2 e NPR- 3 nas células da granulosa não foi alterada por LH e/ou por AG1478 (inibidor do EGFr) após 6 horas de cultivo in vitro. Também em cultivo in vitro de células da granulosa, o LH estimulou a expressão de NPPC, sendo que o AG1478 impediu este aumento. Como forma de comprovar esses resultados in vitro, utilizamos um modelo in vivo e observamos que a expressão do NPPC aumentou e a do NPR-3 diminuiu após 6 horas do desafio com GnRH, nas células da granulosa. De maneira que, a injeção intrafolicular de AG1478 preveniu o efeito do GnRH sobre a expressão do NPPC e NPR-3. Além disso, foi demonstrado que o ANP em associação com o LH estimulou a expressão de COX2 em comparação com LH isoladamente ou ausência desta gonadotrofina. Também foi demonstrado que o bloqueio do EGFr in vivo não foi suficiente para bloquear a ovulação em bovinos. No quarto estudo, foi observado que a expressão do NPR-3 diminui nas células do cumulus pelo tratamento dos CCOs com FSH ou FSH+LH via EGFr em bovinos. Forskolin (estimulador adenilato ciclase) também induziu a diminuição da expressão do NPR-3. A expressão do NPR-1 foi muito baixa no cumulus de bovino e o NPR-2 não apresentou regulação nos tratamentos propostos. Além disso, foi observado que a ativação do NPR-3 por um agonista específico (cANP4-23) não interferiu na maturação nuclear oocitária em bovinos, porém, inibiu a completa expansão das células do cumulus estimulada por FSH+LH. De maneira que, a associação do cANP4-23 com CNP potencializou a inibição da expansão das células do cumulus.

Conselho Nacional de Desenvolvimento Científico e Tecnológico / Endocrine and locally produced factors are involved in the selection of the dominant ovarian follicle in the cow. Studies have been conducted to elucidate the precise mechanism by which, in most cases, only one follicle becomes dominant in monovulatory species. A better understanding of the factors involved in this period can serve as a basis to better exploit the reproductive potential in cattle. A complete knowledge of these factors remains unknown. The receptor peroxisome proliferator activated gamma (PPARγ, also called NR1C3) is a member of the PPAR nuclear receptors family. This family of receptors has been shown to be expressed in reproductive tissues of different species and their role in steroidigenesis and regulation of apoptosis. However, involvement of this receptor in folliculogenesis in cattle remains unknown. This study aimed to evaluate the role of PPARγ during the period of follicle deviation in cattle. At first, the PPARγ mRNA expression was evaluated in granulosa cells of the two largest growing follicles, before (day 2 of the follicular wave), during (day 3) and after (day 4) the follicle deviation period. The mRNA abundance was unchanged during follicular growth in both granulosa and theca cells. In a second experiment, the PPARγ agonist (TZD) was injected intrafollicularly in the dominant follicle in vivo in cows. The agonist caused follicular atresia, demonstrating that the activation of PPARγ in the dominant follicle prevent follicle growth. To determine the mechanism underlying the effects of PPARγ in granulosa cells in vivo, the dominant follicle of each cow was injected with PBS or TZD and the animals were ovariectomized 24 hours post injection. The stimulation of the PPARγ in the dominant follicle reduces the abundance of mRNA encoding the aromatase (CYP19A1) gene, the enzyme responsible for converting androgens to estradiol in granulosa cells and important for follicular development. In conclusion, the increased signaling of PPARγ downregulates aromatase and induces follicular atresia in cattle. / Fatores endócrinos e fatores produzidos localmente estão envolvidos na seleção do folículo dominante. Estudos têm sido realizados no intuito de elucidar o completo mecanismo pelo qual, na maioria das vezes, apenas um folículo torna-se dominante nas espécies monovulatórias. O melhor entendimento dos fatores envolvidos neste período pode servir como base para melhor explorar o potencial reprodutivo dos bovinos. No entanto, o completo entendimento desses fatores permanece desconhecido. O receptor ativado por proliferador de peroxissomo gama (PPARγ, também conhecido como NR1C3) pertence à família de receptores nucleares PPAR e tem sido demonstrado a expressão dessa família de receptores no tecido reprodutivo de diferentes espécies, bem como sua atuação na esteroidogênese e regulação da apoptose. No entanto, pouco se sabe sobre o envolvimento deste receptor na foliculogênese em bovinos. Dessa forma, o presente trabalho teve como objetivo investigar o papel e a regulação do PPARγ durante o período da divergência folicular na espécie bovina. Em um primeiro momento, foi avaliada a expressão de RNAm do PPARγ nas células da granulosa dos dois maiores folículos em crescimento, antes (dia 2 da onda folicular), durante (dia 3) e após (dia 4) o período da divergência folicular. Observou-se que a expressão deste receptor permanece inalterada durante o crescimento folicular nas células da teca e granulosa. Em um segundo experimento, a injeção intrafolicular com o agonista do receptor em estudo (TZD) no folículo dominante ocasionou a atresia dos folículos injetados. Assim, a ativação do PPARγ no folículo dominante impede o crescimento folicular. Para determinar o efeito da ativação do PPARγ, o folículo dominante de cada vaca foi injetado com TZD ou PBS e os animais foram ovariectomizados após 24 horas. A estimulação do PPARγ no folículo dominante diminui a abundância de RNAm que codifica para o gene aromatase (CYP19A1), enzima responsável pela conversão de andrógenos em estradiol nas células da granulosa e importante para o desenvolvimento folicular. Em conclusão, o aumento da sinalização do PPARγ diminui a expressão da enzima aromatase e induz atresia folicular em bovinos.